WHO WE ARE

We are leading experts in FDA and global nicotine and tobacco regulatory strategies,

visionaries on future CBD regulation,European public affairsAND

 corporate compliance, transformation and sustainability strategies

I had the privilege to speak with some of the most inspiring harm reduction thought leaders, who generously shared their views on harm reduction and regulatory strategy. I owe them the inspiration for this platform’s title – RegulationStrategy – as well as the determination to contribute to the unprecedented transformation of our society’s views on nicotine and reduced risk products. Thank you all, again and again, for your invaluable, enlightening perspective and immense patience.